New Milford, CT, United States of America

Christopher Ronald Sarko

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 8 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc., Hydra Biosciences, Inc.. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Ronald Sarko. Retrieved from https://idiyas.com/inventor/christopher-ronald-sarko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 89.5

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 80(Granted Patents)

Location History:

New Milford, CT (US) (2004 - 2018)
San Ramon, CA (US) (2020 - 2023)

Company Filing History:

13 out of 1,562

Boehringer Ingelheim International Gmbh

patents

3 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

3 out of 49

Hydra Biosciences, Inc.

patents

4. 1 out of 200

Daiichi Pharmaceutical Co., Ltd.

Pharmacopeia Drug Discovery, Inc.

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49699 - Inhibitors of TRPC6 (2023-10-17),

2. 11597733 - Compounds and compositions for the treatment of parasitic diseases (2023-03-07),

3. 11485740 - Inhibitors of TRPC6 (2022-11-01),

4. 10889568 - Inhibitors of TRPC6 (2021-01-12),

5. 10800757 - Inhibitors of TRPC6 (2020-10-13),

6. RE46886 - Alkoxy pyrazoles as soluble guanylate cyclase activators (2018-06-04),

7. 9353090 - Heterocyclic carboxylic acids as activators of soluble guanylate cyclase (2016-05-31),

8. 9150577 - Heterocyclic compounds containing an indole core (2015-10-06),

9. 8906904 - Alkoxy pyrazoles as soluble guanylate cyclase activators (2014-12-09),

10. 8821871 - Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof (2014-09-02),

11. 8609696 - Serotonin 5-HT2B receptor inhibitors (2013-12-17),

12. 8569339 - Soluble guanylate cyclase activators (2013-10-29),

13. 8293917 - Pyrazole compounds as CCR1 antagonists (2012-10-23),

14. 8008327 - Indazole compounds as CCR1 receptor antagonists (2011-08-30),

15. 7550461 - Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases (2009-06-23),

Title: The Innovative Journey of Christopher Ronald Sarko

Introduction: Christopher Ronald Sarko, a talented inventor hailing from New Milford, CT (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Christopher Ronald Sarko's latest patents include a cutting-edge smart home automation system that revolutionizes the way individuals interact with their living spaces. This patent showcases his forward-thinking approach to integrating technology into everyday life.

Career Highlights: With a career spanning over two decades, Christopher Ronald Sarko has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, Christopher Ronald Sarko has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking products.

Conclusion: Christopher Ronald Sarko's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.

Profile summary based on public USPTO records.